- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Imnet shares plummet on news of SEC inquiry
Imnet shares plummet on news of SEC inquiryThe stock of information systems developer Imnet Systems plunged 34% late last month after the Atlanta company announced that the release of its year-end financial statements would be delayed because
Imnet shares plummet on news of SEC inquiry
The stock of information systems developer Imnet Systems plunged 34% late last month after the Atlanta company announced that the release of its year-end financial statements would be delayed because its auditor needed additional time to complete the company's audit.
Imnet executives said its auditor, KPMG Peat Marwick, might need the extra time to respond to a confidential informal inquiry made by the Securities and Exchange Commission, which has received anonymous letters regarding the company's financial statements. Imnet shares fell $13.63 to close at $26.88 on Sept. 30, the day the news was announced.
Imnet chairman and CEO Kenneth Rardin stressed that the auditors have not proposed any adjustments to Imnet's financial statements, nor have the auditors had any disagreements with the company over the statements. Rardin said that his company had reviewed the allegations in the letters and determined them to be without merit, and that the company's previously announced financial statements are accurate.
Imnet declined to comment on the nature of the allegations in the letters sent to the SEC. There has been some concern among industry analysts, however, over the size of the company's backlog, which grew to $51 million at the end of the fourth quarter, up 111% compared with $24.2 million at the end of 1996 (PNN 9/97).
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
